P0C1Z0 (TXFA2_DENAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
December 14, 2011.
Version 30.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Fasciculin-2 Short name=Fas-2 Short name=Fas2 Alternative name(s): Acetylcholinesterase toxin F-VII Fasciculin-II Short name=FAS-II Toxin TA1 |
| Organism | Dendroaspis angusticeps (Eastern green mamba) |
| Taxonomic identifier | 8618 [NCBI] |
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Lepidosauria › Squamata › Scleroglossa › Serpentes › Colubroidea › Elapidae › Elapinae › Dendroaspis |
Protein attributes
| Sequence length | 61 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | This three-finger toxin selectively binds and inhibits with a 1:1 stoichiometry the mammalian and electric fish acetylcholinesterase (AChE) at picomolar concentrations. It is highly specific for the peripheral site on acetylcholinesterase. It has been called fasciculin since after injection into mice it cause severe, generalized and long-lasting (5-7 hours) fasciculations. The whole venom has anticoagulant activity, and the various components seem to act synergistically. |
| Subcellular location | |
| Tissue specificity | Expressed by the venom gland. |
| Toxic dose | LD50 is >20 mg/kg by intravenous injection. |
| Sequence similarities | Belongs to the snake three-finger toxin family. Acn-esterase inhibitor subfamily. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Secreted |
| Molecular function | Toxin |
| PTM | Disulfide bond |
| Technical term | 3D-structure Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | modification of morphology or physiology of other organism Inferred from electronic annotation. Source: InterPro |
| Cellular component | extracellular region Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 61 | 61 | Fasciculin-2 | PRO_0000253031 | |||||||||||||||||||||
Sites | |||||||||||||||||||||||||
| Site | 27 | 1 | May interact with AChE | ||||||||||||||||||||||
| Site | 30 | 1 | May interact with AChE | ||||||||||||||||||||||
| Site | 31 | 1 | May interact with AChE | ||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||
| Disulfide bond | 3 ↔ 22 | Ref.5 Ref.6 Ref.7 | |||||||||||||||||||||||
| Disulfide bond | 17 ↔ 39 | Ref.5 Ref.6 Ref.7 | |||||||||||||||||||||||
| Disulfide bond | 41 ↔ 52 | Ref.5 Ref.6 Ref.7 | |||||||||||||||||||||||
| Disulfide bond | 53 ↔ 59 | Ref.5 Ref.6 Ref.7 | |||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||
| Mutagenesis | 8 – 9 | 2 | TT → AA: 18-fold increase in inhibition potency. | ||||||||||||||||||||||
| Mutagenesis | 11 | 1 | R → Q: 6-fold increase in inhibition potency. Ref.3 | ||||||||||||||||||||||
| Mutagenesis | 24 | 1 | R → T: 13-fold decrease in inhibition potency. Ref.3 | ||||||||||||||||||||||
| Mutagenesis | 25 | 1 | K → L: No significant difference in inhibition potency. Ref.3 | ||||||||||||||||||||||
| Mutagenesis | 27 | 1 | R → W: 49-fold decrease in inhibition potency. Ref.3 | ||||||||||||||||||||||
| Mutagenesis | 28 | 1 | R → D: No significant difference in inhibition potency. Ref.3 | ||||||||||||||||||||||
| Mutagenesis | 29 | 1 | H → D: 73-fold increase in inhibition potency. Ref.3 | ||||||||||||||||||||||
| Mutagenesis | 30 | 1 | Missing: 192-fold decrease in inhibition potency. Ref.3 | ||||||||||||||||||||||
| Mutagenesis | 31 | 1 | P → R: 625-fold decrease in inhibition potency. Ref.3 | ||||||||||||||||||||||
| Mutagenesis | 32 | 1 | K → G: 3-fold decrease in inhibition potency. Ref.3 | ||||||||||||||||||||||
| Mutagenesis | 33 | 1 | M → A: 8-fold decrease in inhibition potency. Ref.3 | ||||||||||||||||||||||
| Mutagenesis | 34 – 35 | 2 | VL → AA: No significant difference in inhibition potency. | ||||||||||||||||||||||
| Mutagenesis | 45 | 1 | D → K: No significant difference in inhibition potency. Ref.3 | ||||||||||||||||||||||
| Mutagenesis | 51 | 1 | K → S: No significant difference in inhibition potency. Ref.3 | ||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||
| Beta strand | 2 – 4 | 3 | |||||||||||||||||||||||
| Beta strand | 6 – 9 | 4 | |||||||||||||||||||||||
| Beta strand | 14 – 16 | 3 | |||||||||||||||||||||||
| Turn | 18 – 19 | 2 | |||||||||||||||||||||||
| Beta strand | 22 – 31 | 10 | |||||||||||||||||||||||
| Beta strand | 34 – 40 | 7 | |||||||||||||||||||||||
| Beta strand | 46 – 53 | 8 | |||||||||||||||||||||||
| Turn | 57 – 60 | 4 | |||||||||||||||||||||||
Sequences
References
| [1] | "Snake venom toxins. The purification and amino acid sequence of toxin F-VII from Dendroaspis angusticeps venom." Viljoen C.C., Botes D.P. J. Biol. Chem. 248:4915-4919(1973) [PubMed: 4123919] [Abstract] Cited for: PROTEIN SEQUENCE. Tissue: Venom. |
| [2] | "Fasciculins, anticholinesterase toxins from the venom of the green mamba Dendroaspis angusticeps." Karlsson E., Mbugua P.M., Rodriguez-Ithurralde D. J. Physiol. (Paris) 79:232-240(1984) [PubMed: 6530667] [Abstract] Cited for: CHARACTERIZATION. |
| [3] | "Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom." Marchot P., Prowse C.N., Kanter J., Camp S., Ackermann E.J., Radic Z., Bougis P.E., Taylor P. J. Biol. Chem. 272:3502-3510(1997) [PubMed: 9013597] [Abstract] Cited for: SYNTHESIS, MUTAGENESIS OF 8-THR-THR-9; ARG-11; ARG-24; LYS-25; ARG-27; ARG-28; HIS-29; PRO-30; PRO-31; LYS-32; MET-33; 34-VAL-LEU-35; ASP-45 AND LYS-51. |
| [4] | "Crystals of fasciculin 2 from green mamba snake venom. Preparation and preliminary X-ray analysis." le Du M.H., Marchot P., Bougis P.E., Fontecilla-Camps J.-C. J. Biol. Chem. 264:21401-21402(1989) [PubMed: 2592383] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS). |
| [5] | "Structure of fasciculin 2 from green mamba snake venom: evidence for unusual loop flexibility." le Du M.-H., Housset D., Marchot P., Bougis P.E., Navaza J., Fontecilla-Camps J.-C. Acta Crystallogr. D 52:87-92(1996) [PubMed: 15299729] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), DISULFIDE BONDS. |
| [6] | "Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target." Harel M., Kleywegt G.J., Ravelli R.B., Silman I., Sussman J.L. Structure 3:1355-1366(1995) [PubMed: 8747462] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF COMPLEX WITH ACHE, DISULFIDE BONDS. |
| [7] | "Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex." Bourne Y., Taylor P., Marchot P. Cell 83:503-512(1995) [PubMed: 8521480] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF COMPLEX WITH ACHE, DISULFIDE BONDS. |
| [8] | "Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II." Kryger G., Harel M., Giles K., Toker L., Velan B., Lazar A., Kronman C., Barak D., Ariel N., Shafferman A., Silman I., Sussman J.L. Acta Crystallogr. D 56:1385-1394(2000) [PubMed: 11053835] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.76 ANGSTROMS). |
| [9] | "Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site." Bourne Y., Taylor P., Radic Z., Marchot P. EMBO J. 22:1-12(2003) [PubMed: 12505979] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS). |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PIR | T4EP1A. A01674. | ||||||||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | P0C1Z0. | ||||||||||||||||||||||||||||||||||||||||||||||||
| SMR | P0C1Z0. Positions 1-61. | ||||||||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG006553. | ||||||||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR003571. Snake_toxin. IPR018354. Snake_toxin_BS. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF00087. Toxin_1. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||
| PROSITE | PS00272. SNAKE_TOXIN. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | TXFA2_DENAN | ||||||||
| Accession | Primary (citable) accession number: P0C1Z0 Secondary accession number(s): P01403 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Animal Toxin Annotation Program | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with